Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Rhea-AI Summary

Tactile Medical (TCMD) has announced its upcoming participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, scheduled for March 17th-20th, 2025. The company's management will deliver a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time.

The presentation will be accessible via live audio webcast in the 'Events & Webcasts' section of Tactile Medical's investor relations website. Investors can access the webcast at investors.tactilemedical.com, with a replay option available after the conference.

Tactile Medical specializes in developing and marketing at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company focuses on enabling patients to better manage their conditions through home-based care, while collaborating with clinicians to expand clinical evidence and improve healthcare outcomes.

MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17^th – 20^th. Management will participate in a virtual presentation on Tuesday, March 18^th at 12:00 p.m. Eastern Time.

A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.

About Tactile Systems Technology, Inc. (DBA Tactile Medical)

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com

FAQ

When is Tactile Medical (TCMD) presenting at the Oppenheimer Healthcare Conference 2025?

Tactile Medical will present on Tuesday, March 18th, 2025, at 12:00 p.m. Eastern Time during the virtual Oppenheimer Healthcare Conference.

How can investors access TCMD's Oppenheimer Conference presentation?

Investors can access the live audio webcast through the 'Events & Webcasts' section at investors.tactilemedical.com, with replay available post-conference.

What medical conditions does Tactile Medical (TCMD) treat with their at-home therapies?

TCMD provides at-home therapies for lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease.

What is the main business focus of Tactile Medical (TCMD)?

TCMD focuses on developing and marketing at-home therapies for underserved chronic conditions, helping patients manage their care while collaborating with clinicians to improve healthcare outcomes.